Valuation: Becton, Dickinson and Company

Market Cap 53.98B 48.22B 44.3B 40.23B 75.55B 5,113B 77.45B 529B 213B 2,699B 203B 198B 8,554B P/E 2026 *
40.4x
P/E 2027 * 23.3x
Enterprise Value 69.86B 62.42B 57.33B 52.07B 97.78B 6,618B 100B 684B 275B 3,493B 262B 257B 11,071B EV / Sales 2026 *
3.62x
EV / Sales 2027 * 3.44x
Free-Float
73.18%
Yield 2026 *
2.11%
Yield 2027 * 2.15%
1 day-0.22%
1 week+1.61%
Current month+0.15%
1 month+12.09%
3 months+16.43%
6 months+32.72%
Current year+2.11%
1 week 194.53
Extreme 194.53
199.94
1 month 176.04
Extreme 176.04
200.47
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
259.92
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Chief Tech/Sci/R&D Officer 56 04/12/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
9/28/26 A Sell

Executive/Senior Manager

-76 0.0000%
9/2/26 A Tax

Chief Financial Officer

-190 0.0001%
8/26/26 A Sell

Executive/Senior Manager

-165 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.22%+1.61%+11.77%-23.46% 53.98B
-0.69%+6.11%-11.66%+14.15% 189B
-0.41%+5.25%+9.62%+36.27% 121B
+1.22%+3.03%-13.29%+12.43% 118B
-0.81%+2.79%-42.27%+5.79% 94.78B
+0.79%+4.65%-0.13%+74.46% 64.98B
+0.06%+19.74%-7.04%+56.54% 52.94B
-1.45%-7.57%-2.88%+55.56% 52.3B
+0.13%+3.61%-1.65%-10.44% 35.25B
-2.11%+5.61%+37.30%-14.87% 30.94B
Average -0.21%+4.39%-2.02%+20.64% 81.37B
Weighted average by Cap. +0.09%+4.44%-6.66%+21.79%

Financials

2026 *2027 *
Net sales 19.29B 17.23B 15.83B 14.38B 27B 1,827B 27.68B 189B 76.02B 964B 72.41B 70.86B 3,057B 19.73B 17.63B 16.19B 14.7B 27.61B 1,869B 28.31B 193B 77.74B 986B 74.05B 72.47B 3,126B
Net income 1.41B 1.26B 1.15B 1.05B 1.97B 133B 2.02B 13.78B 5.54B 70.31B 5.28B 5.17B 223B 2.19B 1.96B 1.8B 1.63B 3.07B 208B 3.15B 21.47B 8.64B 110B 8.23B 8.05B 347B
Net Debt 15.88B 14.19B 13.04B 11.84B 22.23B 1,505B 22.79B 156B 62.6B 794B 59.62B 58.35B 2,517B 13.95B 12.46B 11.45B 10.4B 19.53B 1,322B 20.02B 137B 54.98B 698B 52.37B 51.25B 2,211B
Projected Income Statement - Annual - Becton, Dickinson and Company
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
03/11/26 $198.17 -0.22% 1,957,832
02/11/26 $198.60 +0.36% 1,785,137
30/10/26 $197.88 -0.23% 2,920,043
29/10/26 $198.34 +1.63% 2,200,098
28/10/26 $195.16 +0.07% 1,740,470
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Becton, Dickinson and Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
198.17USD
Average target price
195.57USD
Spread / Average Target
-1.31%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Becton, Dickinson and Company